NO885568L - Nye polynukleotidanaloger, fremgangsmaater for inhibering av nukleinsyrepolymeraser og fremgangsmaater til aa induseresyntese av interferon. - Google Patents
Nye polynukleotidanaloger, fremgangsmaater for inhibering av nukleinsyrepolymeraser og fremgangsmaater til aa induseresyntese av interferon.Info
- Publication number
- NO885568L NO885568L NO88885568A NO885568A NO885568L NO 885568 L NO885568 L NO 885568L NO 88885568 A NO88885568 A NO 88885568A NO 885568 A NO885568 A NO 885568A NO 885568 L NO885568 L NO 885568L
- Authority
- NO
- Norway
- Prior art keywords
- poly
- acid
- mercapto
- substituted
- fluoro
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 14
- 102000040430 polynucleotide Human genes 0.000 title claims 11
- 108091033319 polynucleotide Proteins 0.000 title claims 11
- 239000002157 polynucleotide Substances 0.000 title claims 6
- 230000015572 biosynthetic process Effects 0.000 title claims 3
- 238000003786 synthesis reaction Methods 0.000 title claims 3
- 102000014150 Interferons Human genes 0.000 title 1
- 108010050904 Interferons Proteins 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 229940079322 interferon Drugs 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 9
- -1 poly(cytidylic acid) Polymers 0.000 claims 7
- 239000005547 deoxyribonucleotide Substances 0.000 claims 6
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 6
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 claims 5
- 125000001153 fluoro group Chemical group F* 0.000 claims 5
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 239000007858 starting material Substances 0.000 claims 4
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 claims 3
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 claims 3
- 230000000536 complexating effect Effects 0.000 claims 3
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 2
- 229950006790 adenosine phosphate Drugs 0.000 claims 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 239000011737 fluorine Substances 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 230000002194 synthesizing effect Effects 0.000 claims 2
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 claims 1
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 claims 1
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 claims 1
- 229940104302 cytosine Drugs 0.000 claims 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 claims 1
- 229920000140 heteropolymer Polymers 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229940028843 inosinic acid Drugs 0.000 claims 1
- 235000013902 inosinic acid Nutrition 0.000 claims 1
- 239000004245 inosinic acid Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 150000003230 pyrimidines Chemical class 0.000 claims 1
- 229940035893 uracil Drugs 0.000 claims 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 claims 1
- 229940045145 uridine Drugs 0.000 claims 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/133,524 US4882147A (en) | 1987-12-16 | 1987-12-16 | Novel polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO885568D0 NO885568D0 (no) | 1988-12-15 |
| NO885568L true NO885568L (no) | 1989-06-19 |
Family
ID=22459024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO88885568A NO885568L (no) | 1987-12-16 | 1988-12-15 | Nye polynukleotidanaloger, fremgangsmaater for inhibering av nukleinsyrepolymeraser og fremgangsmaater til aa induseresyntese av interferon. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4882147A (da) |
| EP (1) | EP0320807A3 (da) |
| JP (1) | JPH02295A (da) |
| AU (1) | AU2687488A (da) |
| CA (1) | CA1295269C (da) |
| DK (1) | DK696888A (da) |
| IL (1) | IL88589A0 (da) |
| NO (1) | NO885568L (da) |
| NZ (1) | NZ227230A (da) |
| ZA (1) | ZA889207B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5276019A (en) * | 1987-03-25 | 1994-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors for replication of retroviruses and for the expression of oncogene products |
| EP0685457B1 (en) * | 1993-02-19 | 1999-12-15 | Nippon Shinyaku Company, Limited | Glycerol derivative, device and pharmaceutical composition |
| US6383783B1 (en) | 1999-09-21 | 2002-05-07 | 3M Innovative Properties Company | Nucleic acid isolation by adhering to hydrophobic solid phase and removing with nonionic surfactant |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3594278A (en) * | 1968-12-31 | 1971-07-20 | Pabst Brewing Co | Preparation of polynucleotides |
| IL37076A (en) * | 1971-06-16 | 1974-05-16 | Littauer U | A method for stepwise synthesis of oligoribonucleotides of defined sequence using 2'(3')-o-acyl-nucleoside diphosphates and polynucleotide phosphorylase |
| GB1364987A (en) * | 1971-06-19 | 1974-08-29 | Merck Patent Gmbh | Biologically active two component complexes |
-
1987
- 1987-12-16 US US07/133,524 patent/US4882147A/en not_active Expired - Fee Related
-
1988
- 1988-12-05 IL IL88589A patent/IL88589A0/xx unknown
- 1988-12-07 NZ NZ227230A patent/NZ227230A/xx unknown
- 1988-12-08 ZA ZA889207A patent/ZA889207B/xx unknown
- 1988-12-09 EP EP19880120569 patent/EP0320807A3/en not_active Withdrawn
- 1988-12-13 CA CA000585731A patent/CA1295269C/en not_active Expired - Lifetime
- 1988-12-14 AU AU26874/88A patent/AU2687488A/en not_active Abandoned
- 1988-12-15 NO NO88885568A patent/NO885568L/no unknown
- 1988-12-15 DK DK696888A patent/DK696888A/da not_active Application Discontinuation
- 1988-12-15 JP JP63317562A patent/JPH02295A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0320807A2 (en) | 1989-06-21 |
| NO885568D0 (no) | 1988-12-15 |
| EP0320807A3 (en) | 1991-05-08 |
| IL88589A0 (en) | 1989-07-31 |
| CA1295269C (en) | 1992-02-04 |
| JPH02295A (ja) | 1990-01-05 |
| US4882147A (en) | 1989-11-21 |
| ZA889207B (en) | 1989-08-30 |
| AU2687488A (en) | 1989-06-22 |
| DK696888A (da) | 1989-06-17 |
| DK696888D0 (da) | 1988-12-15 |
| NZ227230A (en) | 1990-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4344959B2 (ja) | ヌクレオシド及びオリゴヌクレオチド含有ホウ素クラスター | |
| Ward et al. | Base specificity in the interaction of polynucleotides with antibiotic drugs | |
| Hao et al. | Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2', 3'-dideoxyuridine-5'-triphosphate. | |
| Sterzycki et al. | Synthesis and anti-HIV activity of several 2'-fluoro-containing pyrimidine nucleosides | |
| Sentenac et al. | Initiation of chains by RNA polymerase and the effects of inhibitors studied by a direct filtration technique | |
| KR20190039522A (ko) | 질병 치료를 위한 화합물, 조성물 및 방법 | |
| KR20020013515A (ko) | Ｌ-리보-ｌｎａ 유사체 | |
| Shapiro et al. | Studies on the nucleotide arrangement in deoxyribonucleic acids II. Differential analysis of pyrimidine nucleotide distribution as a method of characterization | |
| Ding et al. | The development of isoguanosine: from discovery, synthesis, and modification to supramolecular structures and potential applications | |
| Tazawa et al. | 2'-O-alkyl polynucleotides. I. Novel procedure for the synthesis of 2'-O-alkyl nucleotides | |
| Sagi et al. | Biochemical properties of oligo [(+)]-carbocyclic-thymidylates] and their complexes | |
| Bergstrom et al. | C-5-Substituted nucleoside analogs | |
| US4997818A (en) | Therapeutic method for selectively treating terminal deoxynucleotidyl transferase-positive neoplastic leukemias and lymphomas | |
| KIRILLOV et al. | Peptidyl transferase antibiotics perturb the relative positioning of the 3′-terminal adenosine of P/P′-site-bound tRNA and 23S rRNA in the ribosome | |
| NO885568L (no) | Nye polynukleotidanaloger, fremgangsmaater for inhibering av nukleinsyrepolymeraser og fremgangsmaater til aa induseresyntese av interferon. | |
| EP3660022A1 (en) | Photoresponsive nucleotide analog capable of photocrosslinking in visible light region | |
| US12060559B2 (en) | Compositions and methods involving non-natural aptamer libraries | |
| CN102516339A (zh) | 嘧啶并嘧啶化合物及其核苷类似衍生物和制备方法及用途 | |
| Spigelman et al. | 2', 3'-Dideoxyadenosine is selectively toxic for TdT-positive cells | |
| US7563887B1 (en) | Universal nucleobase analogs | |
| US6914052B2 (en) | Selective anti-viral nucleoside chain terminators | |
| CN108060165B (zh) | 一种结合α亚基的F1F0-ATP合成酶RNA抑制剂及应用 | |
| Hansbury et al. | Synthesis of polydeoxynucleotides using chemically modified subunits | |
| Mohr et al. | Derepression of Nuclear Template Restrictions for DNA Synthesis by the Immunostimulator Pyran Copolymer | |
| RU2411948C1 (ru) | Средство для ингибирования фермента поли(адф-рибозо)полимеразы-1 человека |